广济药业

- 000952

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
单位:元
广济药业(000952) 财务指标
报告期2008-06-302008-03-312007-12-312007-09-302007-06-30
每股财务数据
每股收益(元)0.3150.22750.78110.44160.11
每股收益增长率(%)180.77751144.1991155.14491013.7516258.0688
每股收益-扣除(元)0.3170.22630.77890.44230.11
每股收益-扣除-增长率(%)188.18181042.9293873.625935.8314254.8387
每股收益-加权(元)0.320.230.780.440.11
每股收益-加权-增长率(%)190.90911177.777812000254.8387
每股收益-扣除/加权(元)0.3200.780.440.11
每股收益-扣除/加权-增长率(%)190.909108750254.8387
每股未分配利润(元)1.46621.48741.28251.02990.7005
每股可分配利润(元)00000.7005
每股净资产(元)2.932.942.712.382.048
每股净资产增长率(%)43.04551.144543.161329.6411-34.6626
每股净资产-调整(元)00000
每股现金含量(元)0.490.441.320.880.396
每股资本公积金(元)0.20110.20110.20110.20110.2011
每股盈余公积金(元)0.26220.25360.23090.14640.1464
每股负债比(%)129.5607127.8251115.2495116.2332129.3024
偿债能力分析
流动比率1.5421.6671.55671.2941.2229
速动比率1.37371.45141.34011.13341.0565
现金流动负债比(%)39.094335.6566118.52581.634739.6366
股东权益比(%)68.966869.338369.780766.687560.807
流动负债率(%)96.933696.891996.552893.163977.263
负债权益比(%)44.225943.447542.456848.891663.1367
经营效率分析
存货周转天(天)50.929568.238759.409951.897151.9286
存货周转率(倍)3.53431.31896.05965.20263.4663
应收款周转天(天)46.701142.547240.182650.479660.5531
应收帐款周转率(倍)3.85432.11538.95915.34872.9726
主营成本比例(%)54.143745.331242.50947.476160.8648
营业费用比例(%)4.17373.64183.29833.57674.2077
管理费用比例(%)9.69695.168511.51210.16099.6102
财务费用比例(%)0.60790.46531.2941.66252.3982
总资产周转率(倍)0.36280.18170.90120.61640.3234
盈利能力分析
经营净利率(%)21.33830.789524.734721.437610.6965
经营毛利率(%)44.747552.613556.610951.609238.363
资产利润率(%)10.36417.474332.078719.31465.327
资产净利率(%)7.7425.595622.2913.21373.4591
净利润率(%)21.33830.789524.734721.437610.6965
净资产收益率(%)10.757.7328.7818.575.48
净资产收益率-增长率(%)96.2861723.1851776.7347759.1035448.03
净资产收益率-扣除(%)10.827.6928.6918.65.49
净资产收益率-扣除-增长率(%)97.0856653.9216544.7191715.7895449
净资产收益率-加权(%)10.97033.6105.63
净资产收益率-加权-增长率(%)94.84901144.81480463
净资产收益率-扣除/加权(%)11.04033.5205.65
净资产收益率-扣除/加权-增长率(%)95.39820813.35150459.4059
税前利润增长率(%)144.0771970.29321009.9696801.896316.5283
扣除非经常性损益后净利润79779757.5156970062.94196053188.67111317853.2928307977.44
成长能力分析
主营收入增长率(%)40.751252.5925104.505181.70238.1901
净利润增长率(%)180.77751144.1991155.14491013.7516426.368
总资产增长率(%)26.120526.270424.728612.4966-3.8572
股东权益增长率(%)43.04551.144543.161329.6411-3.9527
主营利润增长率(%)64.1757147.1356294.8703226.019693.411
财务结构分析
资产负债率(%)30.501230.125829.626632.604638.3915
长期负债资产比(%)0.93530.93631.02132.22898.7291
固定比(%)40.837940.745443.934748.211850.6939
现金流量比率
主营收入现金含量(倍)0.9941.10540.9510.99431.0316
净利润现金含量(倍)1.55861.94081.68842.00193.5295
广济药业(000952) 财务指标
报告期2007-03-312006-12-312006-09-302006-06-302006-03-31
每股财务数据
每股收益(元)0.01830.060.040.0310.015
每股收益增长率(%)19.599424.433221.539597.968724.1158
每股收益-扣除(元)0.01980.080.04270.0310.0153
每股收益-扣除-增长率(%)29.411823.076931.790193.7524.3902
每股收益-加权(元)0.0180.06--0.0310
每股收益-加权-增长率(%)020--93.750
每股收益-扣除/加权(元)00.08--0.0310
每股收益-扣除/加权-增长率(%)023.0769--93.750
每股未分配利润(元)0.59970.55360.53730.76280.7468
每股可分配利润(元)00.55360.53730.76280.7468
每股净资产(元)1.951.91.833.133.12
每股净资产增长率(%)-37.5798-38.8964-40.57152.1351.7285
每股净资产-调整(元)01.791.732.982.93
每股现金含量(元)0.05630.50040.36180.40540.1753
每股资本公积金(元)0.20110.20110.16131.17281.1728
每股盈余公积金(元)0.14570.14140.13520.19880.1988
每股负债比(%)138.1517122.1047133.2932201.2224209.4452
偿债能力分析
流动比率1.22141.25691.11741.49441.4572
速动比率1.00881.03560.96171.29841.2498
现金流动负债比(%)5.244254.834.186127.503511.4104
股东权益比(%)57.927260.796157.868360.867559.7879
流动负债率(%)77.712974.78479.395773.260773.3345
负债权益比(%)70.973664.39772.686764.196967.164
经营效率分析
存货周转天(天)59.398173.512967.562571.247679.8297
存货周转率(倍)1.51524.89713.99632.52641.1274
应收款周转天(天)68.058188.0971108.7789107.5397116.6559
应收帐款周转率(倍)1.32244.08642.48211.67380.7715
主营成本比例(%)67.319169.852771.0772.390272.7182
营业费用比例(%)5.20833.60324.2345.32365.3503
管理费用比例(%)11.356613.497114.312313.005211.8059
财务费用比例(%)2.4793.4293.63273.6144.1045
总资产周转率(倍)0.14950.46620.33970.21660.1
盈利能力分析
经营净利率(%)3.77614.03013.49742.80822.9484
经营毛利率(%)32.485929.319128.763627.409927.1007
资产利润率(%)0.87663.05772.14441.18360.5722
资产净利率(%)0.56451.87891.1880.60820.2949
净利润率(%)3.77614.03013.49742.80822.9484
净资产收益率(%)0.93993.282.1610.49
净资产收益率-增长率(%)91.6038103.643104.513793.830522.0069
净资产收益率-扣除(%)1.024.452.2810.49
净资产收益率-扣除-增长率(%)108.1633113.9423114.891692.307722.5
净资产收益率-加权(%)02.7--10
净资产收益率-加权-增长率(%)066.6667--92.30770
净资产收益率-扣除/加权(%)03.67--1.010
净资产收益率-扣除/加权-增长率(%)074.7619--94.23080
税前利润增长率(%)40.723657.202693.1708118.473641.0035
扣除非经常性损益后净利润4996103.8921240054.1210760180.855385098.592618317.66
成长能力分析
主营收入增长率(%)37.275912.393814.781718.996322.202
净利润增长率(%)75.813482.919278.665497.968724.1158
总资产增长率(%)-5.2937-11.0394-12.8084-3.1802-4.7622
股东权益增长率(%)-8.241-10.1765-12.63892.1351.7285
主营利润增长率(%)64.554337.143753.648460.87337.7132
财务结构分析
资产负债率(%)41.113139.150942.062639.07540.156
长期负债资产比(%)9.16299.87228.666710.448410.7078
固定比(%)50.570448.00647.805543.758843.8168
现金流量比率
主营收入现金含量(倍)0.7781.15320.93180.90780.9772
净利润现金含量(倍)3.07858.04069.124912.940111.4611
广济药业(000952) 财务指标
报告期2005-12-312005-09-302005-06-302005-03-312004-12-31
每股财务数据
每股收益(元)0.050.0330.0160.0120.048
每股收益增长率(%)4.2668-5.1651-39.44639.6131-24.3302
每股收益-扣除(元)0.0650.03240.0160.01230.05
每股收益-扣除-增长率(%)30-6.6282-38.46159.8214-21.875
每股收益-加权(元)0.05--0.016--0.048
每股收益-加权-增长率(%)4.1667---38.4615---23.8095
每股收益-扣除/加权(元)0.065--0.016--0.05
每股收益-扣除/加权-增长率(%)30---38.4615---21.875
每股未分配利润(元)0.73150.72160.70480.70130.689
每股可分配利润(元)0.73150.72160.70480.70130.689
每股净资产(元)3.13.0863.073.073.05
每股净资产增长率(%)1.63820.90820.63091.00930.9773
每股净资产-调整(元)2.922.983.012.952.94
每股现金含量(元)0.31620.22440.03950.0286-0.0194
每股资本公积金(元)1.17281.17281.17281.17281.1728
每股盈余公积金(元)0.19880.19130.19130.19130.1913
每股负债比(%)204.8065225.421224.7346240.8577227.0456
偿债能力分析
流动比率1.34961.40641.391.34221.2778
速动比率1.12851.17381.17111.13361.073
现金流动负债比(%)19.936713.79172.40221.5817-1.0889
股东权益比(%)60.212157.75657.699955.973257.3243
流动负债率(%)77.435772.167273.253275.043678.3621
负债权益比(%)66.000173.052773.228878.572374.3654
经营效率分析
存货周转天(天)84.459588.373987.4976103.8781106.8852
存货周转率(倍)4.26243.05522.05720.86643.3681
应收款周转天(天)111.5587117.9967119.7047128.9583131.7668
应收帐款周转率(倍)3.2272.28821.50370.69792.7321
主营成本比例(%)75.433878.143679.504975.66175.5866
营业费用比例(%)4.44394.35874.56715.03825.7813
管理费用比例(%)9.1917.74577.32137.58658.6383
财务费用比例(%)4.54564.67974.72285.26324.1432
总资产周转率(倍)0.38550.27220.17620.07860.311
盈利能力分析
经营净利率(%)2.47632.24691.6882.90292.9691
经营毛利率(%)24.02821.487620.274924.048224.0295
资产利润率(%)1.80751.0210.52440.38951.426
资产净利率(%)0.95450.61150.29740.22810.9234
净利润率(%)2.47632.24691.6882.90292.9691
净资产收益率(%)1.611.0570.520.41.57
净资产收益率-增长率(%)2.5863-6.0187-39.8268.5179-25.0625
净资产收益率-扣除(%)2.081.0610.520.41.63
净资产收益率-扣除-增长率(%)27.6074-6.1062-39.53498.1081-22.7488
净资产收益率-加权(%)1.62--0.52--1.58
净资产收益率-加权-增长率(%)2.5316---39.5349---25.4717
净资产收益率-扣除/加权(%)2.1--0.52--1.64
净资产收益率-扣除/加权-增长率(%)28.0488---39.5349---23.0047
税前利润增长率(%)27.85251.1224-31.190622.7954-29.9052
扣除非经常性损益后净利润11062242.85556055.812726798.432109576.088521395.63
成长能力分析
主营收入增长率(%)25.01929.501127.645114.595535.5367
净利润增长率(%)4.2668-5.1651-39.44639.6131-24.3302
总资产增长率(%)-3.23642.2973-0.04896.11795.1925
股东权益增长率(%)1.63820.90820.63091.00930.9773
主营利润增长率(%)25.010824.708612.598424.4922-9.2967
财务结构分析
资产负债率(%)39.7442.192342.25343.979442.6295
长期负债资产比(%)8.96711.743311.301310.97579.2241
固定比(%)45.021344.13143.734642.820943.9717
现金流量比率
主营收入现金含量(倍)1.06960.97360.93781.00261.0516
净利润现金含量(倍)6.32186.87772.49862.3205-0.4039
广济药业(000952) 财务指标
报告期2004-09-302004-06-302004-03-312003-12-312003-09-30
每股财务数据
每股收益(元)0.0340.0260.0110.0450.06
每股收益增长率(%)-42.9287-42.1303-14.3973-61.2396-46.3192
每股收益-扣除(元)0.03470.0260.01120.0450.06
每股收益-扣除-增长率(%)-42.1667-42.22220-61.5385-45.4545
每股收益-加权(元)--0.026------
每股收益-加权-增长率(%)0-42.22220--0
每股收益-扣除/加权(元)--0.026------
每股收益-扣除/加权-增长率(%)0-42.22220--0
每股未分配利润(元)0.69830.690.67510.64820.6703
每股可分配利润(元)0.69830.69--0.64820.6703
每股净资产(元)3.063.053.033.013.02
每股净资产增长率(%)1.24211.47612.06841.51932.1655
每股净资产-调整(元)2.992.982.972.942.98
每股现金含量(元)-0.0423-0.1088-0.1453-0.0899-0.1025
每股资本公积金(元)1.17281.17281.17281.17281.1728
每股盈余公积金(元)0.18680.18680.18680.18410.1773
每股负债比(%)216.4762227.1696212.6061205.7983189.8449
偿债能力分析
流动比率1.2681.26351.40811.42021.5549
速动比率1.0621.07091.21561.19871.2875
现金流动负债比(%)-2.4435-5.9144-8.5635-5.5222-6.9671
股东权益比(%)58.551157.310158.804159.353561.4049
流动负债率(%)80.051280.990379.79879.130577.4999
负债权益比(%)70.791174.489270.056168.482162.8534
经营效率分析
存货周转天(天)111.3907114.0468107.5397167.3874195.5105
存货周转率(倍)2.42391.57830.83692.15071.381
应收款周转天(天)143.9463145.9972148.6866171.6084186.2197
应收帐款周转率(倍)1.87571.23290.60532.09781.4499
主营成本比例(%)77.589976.83677.668564.09361.3895
营业费用比例(%)4.02864.36043.9077.66218.4063
管理费用比例(%)8.25027.98599.376112.41212.4136
财务费用比例(%)4.77414.68654.03085.34355.6941
总资产周转率(倍)0.2180.14150.07240.2420.1722
盈利能力分析
经营净利率(%)3.06823.55823.03493.7737.2116
经营毛利率(%)22.313322.984322.136535.90738.6105
资产利润率(%)1.04720.78120.33522.14542.0353
资产净利率(%)0.66890.50340.21990.9131.2418
净利润率(%)3.06823.55823.03493.7737.2116
净资产收益率(%)1.120.860.371.52
净资产收益率-增长率(%)-43.6289-42.9721-16.132-61.8196-47.457
净资产收益率-扣除(%)1.130.860.371.511.99
净资产收益率-扣除-增长率(%)-43.2161-43.0464-15.9091-61.86870
净资产收益率-加权(%)--0.86--1.51--
净资产收益率-加权-增长率(%)0-43.04640-62.250
净资产收益率-扣除/加权(%)--0.86------
净资产收益率-扣除/加权-增长率(%)0-43.42110--0
税前利润增长率(%)-45.4809-45.9788-42.1118-33.6996-37.1008
扣除非经常性损益后净利润5939925.94495507.971924564.937770217.9810305061.57
成长能力分析
主营收入增长率(%)34.141428.369418.19010.9579-4.885
净利润增长率(%)-42.9287-42.1303-14.3973-61.2396-46.3192
总资产增长率(%)6.17688.87046.85495.73623.7235
股东权益增长率(%)1.24211.47612.06841.51932.1655
主营利润增长率(%)-22.4786-28.0575-33.0721-1.7314-0.388
财务结构分析
资产负债率(%)41.448942.689941.195940.646538.5951
长期负债资产比(%)8.26868.11528.32248.48278.6839
固定比(%)43.698542.425543.323843.717742.1599
现金流量比率
主营收入现金含量(倍)0.95460.92930.81021.02671.0361
净利润现金含量(倍)-1.231-4.1632-12.9258-1.9996-1.7007
广济药业(000952) 财务指标
报告期2003-06-302003-03-312002-12-312002-09-302002-06-30
每股财务数据
每股收益(元)0.0450.0130.1160.110.072
每股收益增长率(%)-36.9752-42.5-19.1979---17.6083
每股收益-扣除(元)0.045--0.1170.110.069
每股收益-扣除-增长率(%)-34.78260-17.0213---15.8537
每股收益-加权(元)0.045--0.116--0.072
每股收益-加权-增长率(%)-37.50-19.4444---17.2414
每股收益-扣除/加权(元)0.045--0.117--0.069
每股收益-扣除/加权-增长率(%)-34.78260-17.0213---15.8537
每股未分配利润(元)0.65510.6230.610.62360.583
每股可分配利润(元)0.6551--0.610.62360.583
每股净资产(元)3.012.972.962.962.92
每股净资产增长率(%)3.07053.734.1055--2.7844
每股净资产-调整(元)2.962.952.922.92.86
每股现金含量(元)-0.1443-0.3010.445--0.1932
每股资本公积金(元)1.17281.1731.17281.17281.1728
每股盈余公积金(元)0.17730.1770.17730.15990.1599
每股负债比(%)188.2487185.649182.8281178.5888159.399
偿债能力分析
流动比率1.45371.7491.51911.74451.5957
速动比率1.2121.5041.29141.51111.3482
现金流动负债比(%)-9.0746-22.60128.9791--14.2091
股东权益比(%)61.486261.56261.818962.341464.6549
流动负债率(%)84.444671.64383.99577.401785.3065
负债权益比(%)62.638262.43961.762760.407154.6673
经营效率分析
存货周转天(天)195.6947159.858168.9982163.8548168.6657
存货周转率(倍)0.91980.5632.13021.64781.0672
应收款周转天(天)178.5714171.429162.2791168.823977.9828
应收帐款周转率(倍)1.0080.5252.21841.59932.3082
主营成本比例(%)58.986160.70462.969262.91562.4439
营业费用比例(%)8.44468.5158.06317.51626.1782
管理费用比例(%)13.282614.559.92127.64868.6976
财务费用比例(%)6.0365.4485.10064.9845.491
总资产周转率(倍)0.11830.0650.25560.19120.1306
盈利能力分析
经营净利率(%)7.8934.199.827412.777912.2463
经营毛利率(%)41.011639.09236.889636.867437.3499
资产利润率(%)1.55190.6153.4513.41742.2398
资产净利率(%)0.93350.2732.51212.44311.5998
净利润率(%)7.8934.199.827412.777912.2463
净资产收益率(%)1.50.443.923.82.46
净资产收益率-增长率(%)-38.8528-44.567-22.3844---19.8403
净资产收益率-扣除(%)1.510.443.96--2.35
净资产收益率-扣除-增长率(%)-35.74470-20.1613---18.6851
净资产收益率-加权(%)1.51--4--2.49
净资产收益率-加权-增长率(%)-39.35740-21.4145---19.9357
净资产收益率-扣除/加权(%)1.52--4.04--2.38
净资产收益率-扣除/加权-增长率(%)-36.13450-19.0381---19.0476
税前利润增长率(%)-25.1643-15.401-14.993---6.9157
扣除非经常性损益后净利润7756898.34--20082433.8318736545.0111734728.74
成长能力分析
主营收入增长率(%)-2.214831.418.6296--17.9983
净利润增长率(%)-36.9752-42.5-19.1979---17.6083
总资产增长率(%)8.382410.167.6231--5.5143
股东权益增长率(%)3.07053.734.1055--2.7844
主营利润增长率(%)7.371745.252-6.2408---5.0182
财务结构分析
资产负债率(%)38.513838.43838.181137.658635.3451
长期负债资产比(%)5.99110.96.11098.51025.1934
固定比(%)41.280240.43540.354437.956540.2916
现金流量比率
主营收入现金含量(倍)1.06260.811.0619--0.9675
净利润现金含量(倍)-3.1939-22.8943.8355--2.6961
广济药业(000952) 财务指标
报告期2002-03-312001-12-312001-06-302000-12-312000-06-30
每股财务数据
每股收益(元)0.0230.1440.0870.180.06
每股收益增长率(%)0-19.69150.5183-2.5708-42.0972
每股收益-扣除(元)--0.1410.0820.18--
每股收益-扣除-增长率(%)0-21.6667012.50
每股收益-加权(元)--0.1440.0870.18--
每股收益-加权-增长率(%)0-200-21.73910
每股收益-扣除/加权(元)--0.1410.0820.18--
每股收益-扣除/加权-增长率(%)0-21.6667000
每股未分配利润(元)--0.51140.52630.49240.3893
每股可分配利润(元)--0.56140.52630.49240.3893
每股净资产(元)2.8662.842.8372.812.69
每股净资产增长率(%)01.10655.4757.17759.786
每股净资产-调整(元)--2.782.7762.792.64
每股现金含量(元)---0.1308-0.21080.28360.0104
每股资本公积金(元)--1.17211.17211.17211.1794
每股盈余公积金(元)--0.15990.13840.14780.1209
每股负债比(%)151.794160.5843143.7291113.694290.3386
偿债能力分析
流动比率1.8731.57372.28192.66722.0242
速动比率1.8731.31971.99252.27841.7449
现金流动负债比(%)---9.5381-20.390838.67711.1606
股东权益比(%)65.37863.907866.372171.211274.8567
流动负债率(%)73.33785.414971.920764.502999.0008
负债权益比(%)52.95656.475550.665640.427333.5886
经营效率分析
存货周转天(天)--185.128199.1371273.5147257.6582
存货周转率(倍)--1.94460.90391.31620.6986
应收款周转天(天)95.643207.5526--356.6475381.4367
应收帐款周转率(倍)0.9411.73450.92391.00940.4719
主营成本比例(%)--56.674353.253851.253453.2862
营业费用比例(%)--7.66137.52118.7969.625
管理费用比例(%)--8.89859.59969.42289.1411
财务费用比例(%)--4.51444.4433.7165.0679
总资产周转率(倍)0.0540.25880.12060.20250.1021
盈利能力分析
经营净利率(%)9.57613.211917.538722.822915.3381
经营毛利率(%)35.36642.740446.400847.868446.2804
资产利润率(%)0.7924.46532.62155.54872.3252
资产净利率(%)0.5173.41952.11544.62131.5656
净利润率(%)9.57613.211917.538722.822915.3381
净资产收益率(%)0.7975.053.0666.362.15
净资产收益率-增长率(%)0-20.569942.7052-9.095-63.7623
净资产收益率-扣除(%)--4.962.896.41--
净资产收益率-扣除-增长率(%)0-22.6209000
净资产收益率-加权(%)--5.093.116.59--
净资产收益率-加权-增长率(%)0-22.7618000
净资产收益率-扣除/加权(%)--4.992.946.65--
净资产收益率-扣除/加权-增长率(%)0-24.9624000
税前利润增长率(%)0-12.659225.5931-16.44883.2436
扣除非经常性损益后净利润--24129057.7114050909.8830885191.27--
成长能力分析
主营收入增长率(%)038.730331.6332-24.0292-31.0408
净利润增长率(%)0-19.69150.5183-2.5708-18.215
总资产增长率(%)012.661118.95824.228553.3668
股东权益增长率(%)01.10655.4757.177125.6902
主营利润增长率(%)023.868731.9755-16.6442-13.7771
财务结构分析
资产负债率(%)34.62236.092233.627928.788825.1433
长期负债资产比(%)9.2315.26419.442510.21920.2512
固定比(%)37.14439.92733.764137.978540.286
现金流量比率
主营收入现金含量(倍)--1.17981.20571.2581.423
净利润现金含量(倍)---0.9111-2.42331.58630.1796
广济药业(000952) 财务指标
报告期1999-12-311999-06-301998-12-311997-12-311996-12-31
每股财务数据
每股收益(元)0.180.10.210.260.2
每股收益增长率(%)-13.5863---19.622631.3804--
每股收益-扣除(元)0.16--------
每股收益-扣除-增长率(%)0--------
每股收益-加权(元)0.23--------
每股收益-加权-增长率(%)0--------
每股收益-扣除/加权(元)----------
每股收益-扣除/加权-增长率(%)0--------
每股未分配利润(元)0.3315--0.36880.1882--
每股可分配利润(元)0.3815--0.36880.474--
每股净资产(元)2.67--1.58341.3711--
每股净资产增长率(%)65.7158--15.49-11.5199--
每股净资产-调整(元)2.62--------
每股现金含量(元)0.4005---0.1261----
每股资本公积金(元)1.1716--0.07380.0738--
每股盈余公积金(元)0.1209--0.14080.109--
每股负债比(%)116.5047--154.0949137.6295--
偿债能力分析
流动比率2.24031.3861.341.481.53
速动比率1.86531.0180.860.860.95
现金流动负债比(%)46.2017---8.689----
股东权益比(%)69.252250.8750.679849.904654.79
流动负债率(%)74.399--94.193875.3485--
负债权益比(%)44.3998--97.3173100.3824--
经营效率分析
存货周转天(天)256.8493--327.2727302.521--
存货周转率(倍)1.40160.7661.11.191.6
应收款周转天(天)234.7265--190.4762152.5424--
应收帐款周转率(倍)1.53370.841.892.363.91
主营成本比例(%)55.6108--55.371350.327--
营业费用比例(%)8.898--12.79739.5195--
管理费用比例(%)8.5209--5.35617.2148--
财务费用比例(%)6.8574--6.77177.9998--
总资产周转率(倍)0.3437--0.45320.4888--
盈利能力分析
经营净利率(%)17.7963--15.960122.6785--
经营毛利率(%)43.6274--43.987749.4789--
资产利润率(%)8.5636--8.546912.2402--
资产净利率(%)6.1163--7.233911.0844--
净利润率(%)17.7963--15.960122.6785--
净资产收益率(%)6.995.9313.4119.2712.98
净资产收益率-增长率(%)-47.8543---30.403148.4858--
净资产收益率-扣除(%)----------